| T-Knife GmbH. (9/21/20). "Press Release: T-Knife and Catalent Sign Technology Transfer and Manufacturing Agreement for Autologous T-Cell Receptor-Based Cell Therapy". Berlin & Somerset, NJ. |
2020-09-21 |
| Novo Holdings A/S. (9/17/20). "Press Release: Novo Ventures Co-leads US$83m Series C Financing in Lava Therapeutics". Copenhagen. |
2020-09-17 |
| InflaRx N.V.. (9/17/20). "Press Release: InflaRx Announces Leadership Team Additions with New CFO and Newly Created Position of Chief Strategy Officer". Jena. |
2020-09-17 |
| Qiagen N.V.. (9/17/20). "Press Release: Qiagen Fully Acquires NeuMoDx Molecular, Inc., Rounding Out Portfolio of PCR-based Diagnostic Automation Systems". Hilden & Ann Arbor, MI. |
2020-09-17 |
| Amadeus Capital Partners. (9/15/20). "Press Release: Amadeus Appoints New Partners Edward Kliphuis and Kai Schmitz". London & Bogotá. |
2020-09-15 |
| Proteome Sciences plc. (9/14/20). "Press Release: Appointment of Chief Executive Officer". |
2020-09-14 |
| Neogene Therapeutics, Inc.. (9/14/20). "Press Release: Neogene Therapeutics Raises $110 Million Series A Financing to Develop Next-Generation Fully Personalized Neo-Antigen T Cell Receptor (TCR) Therapies". New York, NY & Amsterdam. |
2020-09-14 |
| Intravacc B.V.. (9/8/20). "Press Release: Intravacc Receives US NIH/NIAID Contract to Develop Enterovirus D68 Vaccine". Bilthoven. |
2020-09-08 |
| Scope Fluidics S.A.. (9/7/20). "Press Release: Poland – EIB Lends up to EUR 10 Million to Scope Fluidics to Develop Diagnostics Dquipment for Infectious Diseases". Luxembourg & Warsaw. |
2020-09-07 |
| Debiopharm International SA. (9/7/20). "Press Release: Belgian Scale-up Oncomfort Raises €10 million in Series A Funding Co-led by Debiopharm and Crédit Mutuel Innovation". Brussels, Lausanne & Paris. |
2020-09-07 |
| CMS. (9/7/20). "Pressemitteilung: CMS begleitet Gründer des KI Start-ups Semalytix bei Serie-A Finanzierungsrunde". Berlin. |
2020-09-07 |
| IcanoMab GmbH. (9/7/20). "Press Release: IcanoMab GmbH Founded with Private Funding to Develop Precision Canonical Monoclonal Antibodies in Oncology, Immune-Modulation, Acute Inflammation and Most Urgently for Covid-19". Polling. |
2020-09-07 |
| EuropaBio. (9/3/20). "Press Release: Novartis’s Andrew Topen Appointed as New Chairman of EuropaBio". |
2020-09-03 |
| IME Medical Electrospinning. (9/3/20). "Press Release: IME Medical Electrospinning Secured € 3 Million in New Financing From Dutch VCs Borski Fund, Lumana Invest, TIIN Capital and From Rabobank to Further Expand its Medispin XL Production Platform". Waal |
2020-09-03 |
| Amarna Therapeutics B.V.. (9/3/20). "Press Release: Dutch Amarna Therapeutics Announces the Appointment of Steen Klysner as Chief Executive Officer". Leiden. |
2020-09-03 |
| Biocartis Group N.V.. (9/1/20). "Press Release: Biocartis Expands Collaboration with LifeArc". Mechelen & London. |
2020-09-01 |
| Semalytix GmbH. (8/31/20). "Press Release: Semalytix Closes Series A Investment Totaling €4.3m". |
2020-08-31 |
| Royal Philips. (8/27/20). "Press Release: Philips to Expand Its Image-guided Therapy Devices Portfolio through Acquisition of Intact Vascular". Amsterdam. |
2020-08-27 |
| NewAmsterdam Pharma B.V.. (8/25/20). "Press Release: NewAmsterdam Pharma Acquires Obicetrapib from Amgen". Naarden. |
2020-08-25 |
| Qiagen N.V.. (8/21/20). "Press Release: Qiagen Announces New Chairman of Supervisory Board". Venlo. |
2020-08-21 |
| Galapagos N.V.. (8/19/20). "Press Release: Galapagos Announces that Gilead Received a Complete Response Letter for Filgotinib for the Treatment of Moderately to Severely Active Rheumatoid Arthritis". Mechelen. |
2020-08-19 |
| Byondis B.V.. (8/19/20). "Press Release: Byondis Announces Appointment of Chief Financial Officer". Nijmegen. |
2020-08-19 |
| MLM Medical Labs GmbH. (8/19/20). "Press Release: MLM Medical Labs Appoints Isabel Struik as VP Sales & Marketing". Düsseldorf. |
2020-08-19 |
| CureVac B.V.. (8/18/20). "Press Release: CureVac Announces Closing of Initial Public Offering". Tübingen & Boston, MA. |
2020-08-18 |
| CureVac B.V.. (8/14/20). "Press Release: CureVac Announces Pricing of Initial Public Offering". Tübingen & Boston, MA. |
2020-08-14 |
| Qiagen N.V.. (8/13/20). "Press Release: Qiagen to Continue Successful Growth Strategy Focused on Execution and Greater Value Creation after Voluntary Public Takeover Offer Falls Short". Venlo. |
2020-08-13 |
| Galapagos N.V.. (8/12/20). "Press Release: Scipher Medicine and Galapagos Sign Collaboration in Inflammatory Bowel Disease". Mechelen & Boston, MA. |
2020-08-12 |
| Atriva Therapeutics GmbH. (8/11/20). "Press Release: Atriva Announces Closing of € 8.6 Million ($ 10.2 Million) Oversubscribed Convertible Loan". Tübingen. |
2020-08-11 |
| Saillant Therapeutics B.V.. (8/11/20). "Press Release: Dutch Saillant Therapeutics to Develop Generic Virus Inhibiting Therapy Based on Activation of a Cellular Master Regulator, Ending Virus Replication". Nijmegen. |
2020-08-11 |
| CureVac B.V.. (8/10/20). "Press Release: CureVac Announces Proposed Initial Public Offering of Common Shares". Tübingen. |
2020-08-10 |
| Dyne Therapeutics Inc.. (8/10/20). "Press Release: Dyne Therapeutics Announces $115 Million Financing to Advance Pipeline of Modern Oligonucleotide Therapeutics for Serious Muscle Diseases". Waltham, MA. |
2020-08-10 |
| Affimed N.V.. (8/5/20). "Press Release: Affimed Announces Two New Appointments to Its Supervisory Board". Heidelberg. |
2020-08-05 |
| CureVac AG. (8/4/20). "Press Release: CureVac Appoints Dr. Franz-Werner Haas as Chief Executive Officer and Dr. Igor Splawski as Chief Scientific Officer". Tübingen. |
2020-08-04 |
| Genespire S.r.l.. (7/30/20). "Press Release: Genespire Appoints Jörn Aldag as Chairman of the Board of Directors". Milan. |
2020-07-30 |
| Vico Therapeutics B.V.. (7/29/20). "Press Release: Biotech Vico Therapeutics Raises $31 Million (€27 Million) in Series A Financing Round to Advance Therapies for Rare Central Nervous System Diseases". Leiden. |
2020-07-29 |
| DNA Script. (7/29/20). "Press Release: DNA Script Expands Series B to $89M". Paris & South San Francisco, CA. |
2020-07-29 |
| Wacker Chemie AG. (7/28/20). "Press Release: Wacker Invests in Amsterdam Biotech Site". Munich & Amsterdam. |
2020-07-28 |
| ExeVir Bio B.V.. (7/28/20). "Press Release: ExeVir Bio to Accelerate Development of New Treatment Conferring Broad Protection Against COVID-19. EUR23M Series A Financing to Advance Lead Novel Llama-derived Antibody into Clinical Trials". Leuven. |
2020-07-28 |
| Citryll B.V.. (7/21/20). "Press Release: Industry Veterans Paul Peter Tak and Eric Meldrum Join Citryll’s Board". Oss. |
2020-07-21 |
| Qiagen N.V.. (7/16/20). "Press Release: Thermo Fisher Scientific and Qiagen N.V. Agree on Amended Terms to Acquisition Agreement". Waltham, MA & Venlo. |
2020-07-16 |
| [iito] Business Intelligence. (7/15/20). "Press Release: [iito] Launches ADucation Campaign Summer 2020". Bremen. |
2020-07-15 |
| iOnctura S.A.. (7/14/20). "Press Release: iOnctura Extends Series A to EUR 20.1m". Geneva. |
2020-07-14 |
| Kiadis Pharma N.V.. (7/13/20). "Press Release: Kiadis Appoints Ray Barlow, Ph.D. as Chief Business Officer and Govert Schouten, Ph.D. as Head of Innovation to Kiadis Management Team". Amsterdam. |
2020-07-13 |
| Novo Holdings A/S. (7/9/20). "Press Release: Major Danish Contribution to Billion-dollar Global Initiative to Combat Antimicrobial resistance". Copenhagen. |
2020-07-09 |
| Belgian Growth Fund. (7/9/20). "Press Release: Final Closing Belgian Growth Fund at 312 Million Euro". |
2020-07-09 |
| Forbion Capital Partners. (7/9/20). "Press Release: Forbion Announces First Close of Forbion Growth Opportunities Fund at EUR 185 million (USD 208 million)". Naarden & Munich. |
2020-07-09 |
| VarmX B.V.. (7/8/20). "Press Release: VarmX Raises €32 million in Series B Financing to Develop Innovative Reversal Agent for the Treatment and Prevention of Severe Bleeding in Patients on Oral Anticoagulants". Leiden. |
2020-07-08 |
| Kiadis Pharma N.V.. (7/8/20). "Press Release: Kiadis Licenses Previously Undisclosed Pre-clinical K-NK-cell Programs to Sanofi, with Total Potential Deal Value of €875 Million, plus Royalties". Amsterdam. |
2020-07-08 |
| CVRx, Inc.. (7/7/20). "Press Release: CVRx Raises $50 Million in New Equity Financing. Offering Will Support US Commercialization of Barostem Neo". Minneapolis, MN. |
2020-07-07 |
| CureVac AG. (7/6/20). "Press Release: EIB and European Commission Provide CureVac with a €75 Million Financing for Vaccine development and Expansion of Manufacturing". |
2020-07-06 |
| S-Biomedic N.V.. (7/2/20). "Press Release: S-Biomedic Is Gearing Up for Significant Growth and Has Appointed a New CCO". Beerse. |
2020-07-02 |
| Citryll B.V.. (7/2/20). "Press Release: Citryll Completes € 18.5 M Fundraise to Develop CIT-013, an Antibody Targeting Neutrophil Extracellular Traps". Oss. |
2020-07-02 |
| Immatics N.V.. (7/2/20). "Press Release: Immatics Announces Completion of Business Combination and Listing on NASDAQ". Houston, TX & Tübingen. |
2020-07-02 |
| Cergentis B.V.. (6/29/20). "Press Release: Cergentis Appoints New CEO and Board Members". Utrecht. |
2020-06-29 |
| BioGeneration Ventures B.V.. (6/24/20). "Press Release: BioGeneration Ventures Closes BGV IV Fund at €105 Million". Naarden. |
2020-06-24 |
| Uniqure N.V.. (6/24/20). "Press Release: Uniqure Announces License Agreement with CSL Behring to Commercialize Hemophilia B Gene Therapy". Lexington, MA & Amsterdam. |
2020-06-24 |
| Scenic Biotech B.V.. (6/23/20). "Press Release: Scenic Biotech Awarded €3.1 Million Innovation Credit from Dutch Government to Progress CD47/QPCTL Immuno-oncology Program". Amsterdam. |
2020-06-23 |
| Qiagen N.V.. (6/23/20). "Press Release: Qiagen Provides Information on Potential Capital Gain from Its Minority Investment in ArcherDX". Venlo. |
2020-06-23 |
| Uniqure N.V.. (6/17/20). "Press Release: Uniqure Announces the Appointment of Leonard E. Post, Ph.D. to Its Board of Directors". Lexington, MA & Amsterdam. |
2020-06-17 |
| Biognosys AG. (6/17/20). "Press Release: Biognosys Announces Appointment of Dr. Patrick Vink as Chairman". Schlieren. |
2020-06-17 |
| Hyloris Pharmaceuticals S.A.. (6/17/20). "Press Release: Hyloris Pharmaceuticals Launches Its Initial Public Offering on Euronext Brussels [Not for US, AU, CA, CH, IL, JP or ZA]". Liège. |
2020-06-17 |
| Illumina, Inc.. (6/17/20). "Press Release: Illumina Acquires BlueBee to Accelerate Processing, Analysis and Sharing of Next Generation Sequencing Data at Scale". San Diego, CA. |
2020-06-17 |
| Ona Therapeutics. (6/16/20). "Press Release: Ona Therapeutics Raises €30m in Series A Financing". Barcelona. |
2020-06-16 |
| eTheRNA Immunotherapeutics N.V.. (6/16/20). "Press Release: eTheRNA Raises EUR 34 Million in Series B Financing to Accelerate Multiple mRNA Therapeutic Development Programs Through to Clinical Proof of Concept". Niel. |
2020-06-16 |
| Bavarian Nordic A/S. (6/12/20). "Press Release: Bavarian Nordic to Manufacture Additional Ebola Vaccines for Janssen". Copenhagen. |
2020-06-12 |
| Affimed N.V.. (6/11/20). "Press Release: Affimed Announces Appointment of Angus Smith as Chief Financial Officer". Heidelberg. |
2020-06-11 |
| Oncoinvent AS. (6/11/20). "Press Release: Oncoinvent Announces Dosing of First Patient with Radspherin in a Second Phase 1 Clinical Trial". Oslo. |
2020-06-11 |
| Bioqube Ventures. (6/10/20). "Press Release: Bioqube Ventures Launches Bioqube Factory Fund I". Hasselt/Brussels. |
2020-06-10 |
| iTeos Therapeutics Inc.. (6/9/20). "Press Release: iTeos Therapeutics Strengthens Leadership Team. Matthew Gall Joins as Chief Financial Officer". Cambridge, MA & Gosselies. |
2020-06-09 |
| Boehringer Ingelheim. (6/8/20). "Press Release: New Consortium EUbOPEN Will Provide Tools to Unlock Disease Biology. 66 Million Euros to Generate Open-access Chemical Tools". Frankfurt & Ingelheim. |
2020-06-08 |
| Immatics Biotechnologies GmbH. (6/4/20). "Press Release: Immatics Appoints Cedrik Britten as Chief Medical Officer". Houston, TX & Tübingen. |
2020-06-04 |
| Prilenia Therapeutics B.V.. (6/3/20). "Press Release: Prilenia Therapeutics Raises $62.5m to Fund Late Stage Trials in HD and ALS". Naarden & Herzliya. |
2020-06-03 |
| Hyloris Pharmaceuticals S.A.. (6/3/20). "Press Release: Hyloris Pharmaceuticals Announces Intention to Launch an Initial Public Offering on Euronext Brussels [Not for US, AU, CA, CH, IL, JP or ZA]". Liège. |
2020-06-03 |
| Argenx SE. (5/29/20). "Press Release: Argenx Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs". Breda & Ghent. |
2020-05-29 |
| Miltenyi Biotec B.V. & Co. KG. (5/28/20). "Press Release: Miltenyi Biotec Launches World’s First Fully Automated Light Sheet Microscope". Bergisch Gladbach. |
2020-05-28 |
| Argenx SE. (5/28/20). "Press Release: Argenx Raises $750 Million in Gross Proceeds in a Global Offering". Breda & Ghent. |
2020-05-28 |
| High-Tech Gründerfonds Management GmbH. (5/27/20). "Press Release: Kumovis Closes Series A Funding Led by Renolit and Solvay". |
2020-05-27 |
| Hyloris Pharmaceuticals S.A.. (5/26/20). "Press Release: Hyloris Appoints Patrick Jeanmart as Chief Financial Officer". Liège. |
2020-05-26 |
| Argenx SE. (5/26/20). "Press Release: Argenx Announces Launch of Proposed Global Offering". Breda & Ghent. |
2020-05-26 |
| Argenx SE. (5/26/20). "Press Release: Argenx Announces Positive Topline Phase 3 ADAPT Trial Results". Breda & Ghent. |
2020-05-26 |
| Dyne Therapeutics Inc.. (5/19/20). "Press Release: Dyne Therapeutics Accelerates Programs in Facioscapulohumeral Muscular Dystrophy (FSHD) with Exclusive Licensing of Technologies to Target Genetic Basis of FSHD and Expanded Scientific Advisory Board". W |
2020-05-19 |
| Syngulon S.A.. (5/16/20). "Press Release: Enzymicals and Syngulon Sign a Non-exclusive License Agreement on the Use of Syngulon’s Antibiotic Free Technology to Produce Enzymes". Seraing. |
2020-05-16 |
| Lava Therapeutics B.V.. (5/15/20). "Press Release: Lava Therapeutics Announces Collaboration with Janssen to Develop Bi-specific Gamma-Delta T-cell Engager Therapeutics". Utrecht. |
2020-05-15 |
| Polyganics B.V.. (5/13/20). "Press Release: Polyganics Awarded €1.2 Million for Clinical Development of Liver and Pancreas Sealant Patch". Groningen. |
2020-05-13 |
| Innovative Medicines Initiative (IMI). (5/12/20). "Press Release: IMI Announces COVID Projects, Boosts Funding Pot to EUR 72 million". Brussels. |
2020-05-12 |
| [iito] Business Intelligence. (5/4/20). "Press Release: [iito] Brings Back the Past into the [LSE] Newsletter". Bremen. |
2020-05-04 |
| Hyloris Pharmaceuticals S.A.. (4/30/20). "Press Release: Hyloris Pharmaceuticals Successfully Raises €15 Million in Funding Round". Liège. |
2020-04-30 |
| Bone Therapeutics S.A.. (4/29/20). "Press Release: Bone Therapeutics Secures EUR 11.0 Million Financing". Gosselies. |
2020-04-29 |
| Kurma Partners. (4/29/20). "Press Release: Kurma Partners Announces the Final Closing of Its Kurma Biofund III Fund at €160 Million". Paris. |
2020-04-29 |
| Genedata AG. (4/28/20). "Press Release: Genedata Partners with Cergentis to Provide End-to-end Solution for Automating TLA-based Clone Selection". Basel. |
2020-04-28 |
| FoRx Therapeutics AG. (4/22/20). "Press Release: FoRx Therapeutics AG Raises EUR 10 Million Seed Round". Basel. |
2020-04-22 |
| Centogene B.V.. (4/17/20). "Press Release: Centogene and Ubirch Create Secure Blockchain Solution for the Successful Fight Against COVID-19". Rostock & Cologne. |
2020-04-17 |
| Galapagos N.V.. (4/16/20). "Press Release: Galapagos and Ryvu Announce Research Collaboration". Mechelen & Krakow. |
2020-04-16 |
| Eurofins Scientific. (4/16/20). "Press Release: Eurofins Genomics Launches »SARS-CoV-2 Full-length Genome Sequencing« Service to Support Researchers Globally in Their Fight against the COVID-19 Pandemic and Outbreak Source Tracing". Ebersberg. |
2020-04-16 |
| Centogene B.V.. (4/15/20). "Press Release: Centogene Announces Opening of Laboratory in Hamburg, Germany". Cambridge, MA, Rostock & Berlin. |
2020-04-15 |
| Halix B.V.. (4/15/20). "Press Release: Halix Enters Collaboration with the University of Oxford for GMP Manufacturing of a COVID-19 Vaccine". Leiden. |
2020-04-15 |
| GlaxoSmithKline plc. (4/14/20). "Press Release: Sanofi and GSK to Join Forces in Unprecedented Vaccine Collaboration to Fight COVID-19". London. |
2020-04-14 |
| Gadeta B.V.. (4/7/20). "Press Release: Gadeta Appoints Marco Londei as Chief Executive Officer". Utrecht. |
2020-04-07 |
| iTeos Therapeutics Inc.. (4/1/20). "Press Release: iTeos Therapeutics Closes $125 Million Series B2 Financing". Cambridge, MA & Gosselies. |
2020-04-01 |
| InflaRx N.V.. (3/31/20). "Press Release: InflaRx Doses First Patient in Multicenter Randomized Clinical Trial in Severe Progressed COVID-19 Pneumonia in Europe upon Receipt of Initial Positive Human Data with InflaRx’s anti-C5a Technology". Jena. |
2020-03-31 |
![[LSBNL] Life-Sciences-Benelux.com - The Benelux Life Sciences Web Portal](/images/basics/lsbnl-life-sciences-benelux-portal-logo-2019.png){kind=logo}
Date
![Picture [iito] Made Without Love 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-made-without-love.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
